As of Dec 09
| +0.50 / +18.52%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +181.25% increase from the last price of 3.20.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.